Mycoplasma pneumoniaeand viruses in acute respiratory tract infections in children were studied during the winter of 1992-1993 in Antwerp, Belgium. M. pneumoniae was diagnosedin nasopharyngeal aspirates by culture and polymerase chain reaction (PCR). For this, amplificationof a fragment of the P1 adhesin gene in samples prepared by two methods was compared in two laboratories, and in one laboratory, a fragment of the 16S rRNA gene was amplified. The sensitivityof culture versus PCR was 61.5%. Provided a specific internal control is used, sample preparation by freeze-boiling combined with PCR for the P1 gene and amplicon detection by visual inspection of the electrophoresis gel can be recommended,although maximal results are obtained after hybridization.M. pneumoniae was present in 0.5% of patients <2 years old and 6.9% of patients > 2. M. pneumoniae was second to respiratory syncytial virus or detected equally in lower respiratory infections. Presently, PCR seems to be the most promising direct technique because of its high sensitivity and specificity. Several procedures for sample preparation and different primer sets for the detection of M pneumoniae have been described; the targets are the gene coding for the PI adhesion protein, the 16S rRNA gene, and a DNA sequence specific for M. pneumoniae selected from a genomic library [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . However, no comparative studies were done on the sensitivity and specificity of different sample preparation methods and primer sets on large series of clinical samples. In addition, most epidemiologic data on the role of M pneumoniae in respiratory tract infections are based on serologic tests.
Presently, PCR seems to be the most promising direct technique because of its high sensitivity and specificity. Several procedures for sample preparation and different primer sets for the detection of M pneumoniae have been described; the targets are the gene coding for the PI adhesion protein, the 16S rRNA gene, and a DNA sequence specific for M. pneumoniae selected from a genomic library [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . However, no comparative studies were done on the sensitivity and specificity of different sample preparation methods and primer sets on large series of clinical samples. In addition, most epidemiologic data on the role of M pneumoniae in respiratory tract infections are based on serologic tests.
We present a study on the etiology of acute respiratory tract infections in children during the winter of 1992-1993 conducted with the following objectives: to evaluate PCR for the diagnosis of respiratory M pneumoniae infections, comparing two procedures of sample preparation and the use of two sets of primers in two laboratories; to define the procedure best suited for the clinical diagnostic laboratory; and to define the incidence ofM pneumoniae in acute respiratory tract infections and the respective role of M. pneumoniae and viruses in the different clinical presentations of acute respiratory tract infections.
Materials and Methods
Patients. Between October 1992 and March 1993, 371 nasopharyngeal aspirates, 1 per episode of acute respiratory tract infection, were obtained from 341 children (mean age, 33 months; range, 1-189) presenting at the outpatient department with or hospitalized for acute respiratory symptoms at University Hospital, Antwerp .
Specimen collection and sample handling for virus detection. Nasopharyngeal aspirates were collected for the detection of vi- Ieven et a1. lID 1996; 173 (June) ruses at the microbiology laboratory of University Hospital, Antwerp (laboratory 1) and processed as described [22] . In brief, aspirates were collected with a mucus extractor (Vygon, Ecouen, France) and, without addition of any transport medium, delivered to the laboratory within 2-4 h. The specimens were processed immediately, except on Saturdays and Sundays, when they were kept at 4°C until the next Monday. Nasopharyngeal aspirates were diluted with an equal volume of sterile PBS, homogenized with a pipette to break up the mucus, and divided into three equal parts.
One portion was used in the PCR and cultured for M. pneumoniae. The second portion was rinsed two or three times in PBS by centrifugation for 5 min at 900 g, the sediment was resuspended in 100 J.lL of PBS, and 20-J.lL aliquots were spotted on multispot slides (lCN, Costa Mesa, CA). These were air-dried, fixed in cold acetone, and examined by indirect immunofluorescence with monoclonal antibodies (MAbs) for the detection of respiratory syncytial virus (RSV) and influenza virus. The third portion was mixed with an equal volume of MEM containing gentamicin, 50 J.lg/mL, and vortexed with glass beads for I min; 200 J.lL was inoculated, respectively, into roller tubes of MRC-5 cells maintained at 33°C and into shell vial cultures of MDCK cells for the detection of influenza virus, Vero cells for parainfluenza viruses, and HL cells for adenoviruses. The vials were centrifuged at 3000 g for 30 min and incubated at 33°e. After 48 h, the coverslips were rinsed, fixed with methanol, and examined by indirect immunofluorescence. The MAbs used were RSV (13-1 and 25-2; Ortho Diagnostic Systems, Raritan, NJ), a mixture of anti-influenza A (clone IA 52; Biosoft, Cambridge, UK) and anti-influenza B viruses (clone IB-82; Biosoft), a mixture of MAbs directed against the three parainfluenza virus serotypes (clones 225-441, 128.3, and 5/12; Biosoft), and an anti-adenovirus MAb (clone BI 011; Biosoft). Samples positive for influenza virus were reexamined with anti-influenza A and anti-influenza B sera separately. The roller tubes were examined twice weekly for the appearance of a cytopathic effect and identified by classical methods.
Culture and PCR reactions for M. pneumoniae. For culture (done only in laboratory 1), a 0.2-mL aliquot ofthe nasopharyngeal aspirates was inoculated into 2 mL of spiroplasma broth (SP4) [23] in 4.5-mL screw-cap containers; from this, three serial 20-fold dilutions in SP4 were made. Media were incubated aerobically at 37°C and examined twice weekly. When color change was noticed, subcultures were made on SP4 agar medium incubated in a humidified container at 37°e. These were examined weekly for the presence of typical M pneumoniae colonies and identified after subculturing in fresh SP4 broth by a PCR with the primers for the PI gene.
For the PCR assay, samples were divided into two portions and distributed to laboratory 1 and the Diagnostic Center, Delft (laboratory 2). Each laboratory applied one extraction procedure on O.I-mL samples. Extracted samples were exchanged between laboratories; identical primers were used in the PCR directed against the PI adhesin gene, while laboratory 2 also used primers directed against the I6S ribosomal gene. Sample preparation method A (done in laboratory 1) consisted of 5 cycles of 2 min each of freezing (liquid N 2 ) and boiling (water bath). In method B (done in laboratory 2), samples were treated with guanidine isothiocyanate followed by phenol-chloroform extraction [24] . To a O.I-mL sample, 500 f.-lL of solution D (4 M guanidinium isothiocyanate, 25 mM sodium citrate [pH 7], 0.5% sarcosyl, 0.1 M (3-mercaptoethanol, 20 mg/mL poly A) was added. After mixing, 0.5 mL of phenol was added and the solution vortexed briefly; 0.2 mL of chloroform-isoamyl alcohol (24: 1, vol/vol) was added and shaken for 10 min. The solution was centrifuged for 20 min at 10,000 g at room temperature. The aqueous phase was removed and extracted with phenol-chloroform-isoamyl alcohol (25:24:1, vol/vol/vol) and chloroform-isoamyl alcohol (24:1), respectively. After the addition of sodium acetate to 0.3 M, the DNA was precipitated with isopropanol, collected, washed once with 80% ethanol, and dried. The pelleted DNA was resuspended in 100 J.lL of double-distilled water.
Two sets of primers were used. One primer set (5'-GCCACCC-TCGGGGGCAGTCAG-3' and 5' -GAGTCGGGA TTCCCCGCG-GAGG-3') was directed against the PI adhesion gene [25] and generated a fragment of 209 bp [26] . Preliminary experiments had shown that no amplification occurred with DNA from M. genitalium, Mycoplasma fermentans, Mycoplasma primatum, Mycoplasma salivarium, Mycoplasma orale, Mycoplasma hominis, Ureaplasma urealyticum, or other bacteria encountered in respiratory material [9] . The second set (5' -AAGGACCTG-CAAGGGTTCGT-3' and 5'-CTCTAGCCATTACCTGCTAA-3') was directed against a species-specific sequence of the 16S ribosomal gene and generated a fragment of 277 bp [10] . The corresponding probes were as follows: for the PI gene, 5' -CTGAACG-GGGGCGGGGTGAAGG-3'; and for the 16S rRNA gene, 5'-ACTCCTACGGGAGGCAGCAGTA-3'.
Laboratory 1 performed the PCR reactions in a total volume of 50 f.-lL, using 1 U of Taq polymerase (AmpliTaq; Perkin Elmer, Foster City, CA), 200 J.lM each dNTP, 1.5 mM MgCh, 5 pmol of each primer, and 5 J.lL of sample. The solution was overlaid with mineral oil and subjected to 40 cycles of amplification. Laboratory 2 performed the PCR reactions in a volume of 100 J.lL, using 1 U ofTaq polymerase (Promega, Madison, WI), 200 J.lM each dNTP, 2.5 mM MgCh, 50 pmol of each primer, and 10 J.lL of sample DNA. The primers were annealed to the target at 52°C for the 16S rRNA gene and at 65°C for the PI adhesion gene. After amplification, 20 J.lL of the sample was electrophoresed in a 2% agarose gel in 0.5X TRIS-borate-EDTA buffer; samples were visually inspected and results were recorded as :2:, slightly visible; +, clearly visible; ++, strong signal. Next, they were blotted on a nylon membrane (Hybond N +; Amersham, Amersham, UK) by vacuum blotting in 0.4 M NaOH. To confirm the identity of the PCR products, the membranes were hybridized with 32p end-labeled probes, corresponding to the respective amplicons, and autoradiographed. In the reaction using the PI primers, a specific internal control, constructed by insertion of a 680-bp fragment of foreign DNA between the two amplicon sites of the target DNA [26] , was added to detect possible inhibitors of the reaction. When inhibitors were detected, the PCR was repeated with a 1/10 dilution of the sample.
Interpretation. Samples were defined as positive if culture was positive for M. pneumoniae, if culture and PCR for PI and/or the I6S gene were positive, or if PCR was positive for both PI and the 16S gene after a particular extraction procedure. Samples positive by PCR for only one of both primer pairs were considered contaminated. Clinical data. Clinical data were extracted from medical records following a standardized protocol. Seven definitions were applied: common cold, rhinorrhea with or without cough with normal auscultation; laryngitis, stridor and barking cough; asthma, age > 2 years, wheezing, normal chest radiograph or showing hyperinflation or increased trauma; acute bronchitis, cough with rhonchi and normal chest radiograph; acute bronchiolitis, age <2 years, wheezing, normal chest radiograph or hyperinflation or increased trauma; bronchopneumonia, diffuse infiltrations on chest radiograph; lobar pneumonia, lobar pulmonary infiltration on chest radiograph. When symptoms belonging to two clinical categories were present, the case was classified in the category of more severe disease.
Results
Evaluation of the two peR methods. Thirteen of the 371 samples met the criteria described above: 8 samples were positive for M. pneumoniae by culture and PCR, and 5 additional samples were positive after PCR only (table 1). The incidence of M. pneumoniae in the population studied was thus 3.5%. The sensitivity of culture compared with PCR was 61.5%.
After sample preparation method A, laboratory 1 identified 9 of the 13 positive samples and 2 more after diluting them 1:10 to eliminate the polymerase inhibitors detected by the presence of the internal control. After hybridization, 1 more positive sample was identified. Laboratory 2, using the same material, obtained similar results, except for sample 4, which was positive only after hybridization. The 16S rRNA gene primers identified only 9 of the 13 positive samples after extraction method A.
There was no relationship between the strength of the electrophoresis bands and the severity of the disease, both weak and strong bands being spread equally (P = .6) among lower and upper respiratory tract infections.
Among the M. pneumoniae-negative samples, 24.6% contained polymerase inhibitors. None of them produced a positive result after 1:10 dilution or extraction method B.
After sample preparation method B, the primers directed to the PI adhesin gene identified 12 samples in laboratory 1 and all 13 samples in laboratory 2 after hybridization; the 16S rRNA primers identified 12 samples after hybridization.
Contamination occurred in 29 samples. These samples were positive after only one ofthe extraction methods with one of the primer sets and after hybridization only; 23 of these occurred in two successive runs in which the negative controls produced a positive result. These 23 samples were retested and interpreted as false-positive results. However, in 6 samples (0.2% of the reactions), contamination was not detected by a simultaneous positive signal in the negative controls. Table 2 shows the sensitivity, specificity, and positive and negative predictive values for each protocol after gel electrophoresis and hybridization. The sensitivity of the test using the PI adhesin gene primers and hybridization was 92.3%-100% in both laboratories; the sensitivity of the test using the 16S ribosomal gene primers was 69.2% after sample preparation A and 92.3% after sample preparation B. The interlaboratory re-lID 1996; 173 (June) sults were in good agreement, with a sensitivity of 91.6% and a specificity of 100% (results not shown). Only one protocol had a sensitivity of 100%-extraction method B with primers PI, after hybridization, in laboratory 2-but the same protocol had a sensitivity of 92.3% in laboratory 1. The specificities of all protocols ranged from 98.6% to 100%. The positive predictive values of all protocols were 100% except for two of them after hybridization. The negative predictive values of the results of the visual inspection of the electrophoresis gels were 98.3%-99.7% for all protocols and 99.7%-100% after hybridization. Epidemiology. Among the 371 episodes of acute respiratory tract infection studied, 114 etiologic agents (30.7%) were identified.
One hundred one viruses were detected (table 3) . They were (in decreasing order) RSV, 61 (16.4%); influenza viruses, 21 (5.6%); adenoviruses, 10 (2.7%); rhinoviruses, 5 (1.3%); parainfluenza viruses, 2 (0.5%); and herpes simplex and varicellazoster viruses, 1 each. The influenza viruses were type B.
Between October 1992 and March 1993, a mean of 62 samples was collected monthly. However, there was a considerable peak in November and December (156 samples) and a smaller one in March (72 samples). The first peak was caused by RSV and the second by influenza virus infections (figure 1). During both of these periods, there was also an increased activity of M pneumoniae.
The distribution of the respiratory agents by age is presented in table 3. All M. pneumoniae infections except 1 (92.3%) were in children >2 years old and 9 (69.3%) of 13 in children > 5 years. This is in contrast with the findings for RSV and adenovirus, which occur most frequently below the age of 2 years (70.5% and 70% of the total, respectively), while influenza virus was found about equally in both age groups.
Incidence ofetiologic agents in the different types ofclinical diseases. Table 4 shows the relative importance of the etiologic agents in the different acute respiratory syndromes. Common colds represented 41.8% of the total, followed by acute bronchitis (22.4%), acute bronchiolitis (12.7%), and pneumonia (lobar pneumonia and bronchopneumonia; 12.1%); asthma and laryngitis represented 7.8% and 3.5%, respectively. The proportions in which etiologic diagnoses were made were higher for the lower respiratory tract infections: acute bronchiolitis (44.7%), bronchopneumonia (44.8%), acute bronchitis (37.8%), and lobar pneumonia (37.5%), compared with common colds (22.6%), acute asthma (24.1%), and laryngitis (7.7%) (P < .001).
In each clinical category, RSV was the most frequently detected agent. The widest range of different agents was found for common colds, with a majority of RSV followed by influenza virus and adenovirus. The importance of M. pneumoniae increased in lower compared with upper respiratory tract infections, since it represented 16.1%, 23.1 %, and 50.0% of all etiologic agents detected in acute bronchitis, bronchopneumonia, and lobar pneumonia, respectively, and only 2.9% of etiologic agents in common colds (P < .001). RSV was equally important in upper and lower respiratory tract infections (P > .05) but was the most important pathogen in bronchiolitis and asthma. Influenza viruses were associated equally with upper and lower respiratory tract infections (P > .05 for each form of lower respiratory tract infection vs. common colds). Most of the small number of adenoviruses detected were present in cases ofcommon colds. There were only 2 parainfluenza viruspositive specimens during this season. Rhinoviruses were mainly found in patients with common colds but also in 1 case each of acute bronchiolitis and asthma. Two double infections with M. pneumoniae and RSV were diagnosed. Discussion PCR in general offers the potential for a rapid and sensitive assay for the diagnosis of infections caused by organisms that grow slowly in vitro or organisms for which growth conditions are suboptimal, leading to a low sensitivity of the culture technique. The low sensitivity of the culture of M. pneumoniae (23%-64%) has been well documented by comparison with serologic results [6, 7] . However, for diagnostic purposes serology offers no alternative, because significant rises in IgG titers appear late, after 2-3 weeks, and detection of IgM is often unreliable [5] .
For PCR to be applicable in the diagnostic microbiology laboratory, sample preparation and amplicon detection should be as simple as possible. In the present study, an extensive sample preparation method, guanidine isothiocyanate treatment followed by phenol-chloroform extraction, was compared with the simpler and more rapid freeze-boiling method. Two primer sets and amplicon detection by visual inspection of the gels and after hybridization, in two laboratories, were also compared.
The major difficulties for the interpretation of the PCR data are the possible false-positive and false-negative results, the 30 former due to contamination, the latter resulting from polymerase inhibitors. In the absence of a reference standard with sufficiently high sensitivity for M. pneumoniae, it was decided to accept PCR-positive but culture-negative results as definitely positive only for the samples producing a positive PCR result with both primer sets after one particular sample preparation procedure, since contamination by an amplicon would produce a positive result with only one ofthe primer sets. False-negative results in the reactions with the PI primers were detected by the inclusion of a specific internal control. There was a high rate, 26.4%, of PCR inhibitors in the undiluted nasopharyngeal aspirates. This is comparable with the recent findings of Reznikov et al. [27] , who detected PCR inhibitors in 36% ofnasopharyngeal aspirates compared with none of throat swabs. We collected nasopharyngeal aspirates because these are preferable for virus detection.
Contamination of whole runs occurred twice, was visualized only after hybridization, and was readily detected by the positive results in the negative control tubes. These contaminations resulted most probably from strong positive samples present in these runs. Based on the above mentioned interpretation rules, false-positive results, undetected by the negative controls included in the test runs, occurred in only 6 (0.2%) of the samples and again only after hybridization. Inhibitors were present in a quarter of the samples after freeze-boiling, but these can be eliminated by dilution of the samples without significant loss of sensitivity. Based on the criteria adopted, the sensitivity of the culture compared with PCR is 61.5%.
As illustrated in table 2, the sensitivity of the PCRs in the two laboratories was not significantly influenced by the different sample volumes used in the reactions (5 J.LL in laboratory 1 vs. 10 J.LL in laboratory 2). The sensitivity after visual inspection of the gels was always lower in laboratory 2 than in laboratory 1. Laboratory 2 systematically performs hybridization for all PCRs, whereas laboratory I, except for the present study, does so only for special cases. Therefore, there was a tendency for laboratory 2 to pay somewhat less attention to the inspection of the electrophoresis gels before hybridization.
Amplicon detection by hybridization was more sensitive than visual inspection of the gel in 5 of the 6 protocols (table I) . Extraction method A is not suited for amplification of the 168 rRNA gene, for which the more elaborated extraction method B should be applied. The PI adhesin gene primers are more sensitive than the 168 rRNA primers; this most likely results from the presence of multiple copies of the P I sequence in the genome.
There are very few studies on interlaboratory comparisons ofPCR protocols. In the present study, prepared samples, primers, and hybridization probes were exchanged between laboratories, each of them applying its own, slightly different amplification protocols. As can be seen from tables I and 2, this interlaboratory comparison is quite satisfactory. The main difference with sample preparation method B and the P I primers after visual inspection of the gels was not statistically significant (P = .3) and disappeared completely after hybridization.
For the diagnostic laboratory, the optimal combination of sample preparation-primer set is the freeze-boiling method and the P I primer set with visual inspection of the gel, more so since a specific internal control is available for this PCR, allowing the detection of eventual inhibitors. This procedure has the advantage of simplicity and rapidity. It does not use radioactive reagents and avoids false-positive results, since most of these appear after hybridization, resulting in lower positive predictive values, and it has a sensitivity of 84.6% and a specificity of 100%. If needed, positive results can be confirmed by repeating the test on a second aliquot of the sample.
Until now, the precise incidence of M. pneumoniae in acute respiratory tract infections was unknown because surveillance is not done and laboratory confirmation is usually not obtained. During the period studied, the global incidence of M pneumoniae in the pediatric population was 3.5% but differed considerably among age groups and in different types of clinical disease. Whereas R8V is more prevalent in very young children, M. pneumoniae infections are found predominantly in children above the age of 2 years. These data are in agreement with epidemiologic data based on serologic studies [2] . M pneumoniae was found in 13.3% of lower respiratory tract infections (bronchopneumonia and lobar pneumonia) as opposed to 2.1% of all other clinical presentations (P < .01). M. pneumoniae was the third most frequently detected agent after RSV and influenza virus (table 4) .
The 8 isolates of M. pneumoniae belonged to type 1, presently the most frequently isolated type [28] .
Based on our previous findings [3] , we limited the detection of RSV to immunofluorescence on nasopharyngeal aspirate samples, omitting culture, since the latter does not add significantly to the former, for a considerable decrease in work load and cost. For influenza virus, both immunofluorescence of the samples and immunofluorescence of shell vial cultures were done. During this season, 7 of 21 cases of influenza virus infection were detected by culture and not by immunofluorescence of the sample. The incidence of the different virus groups is comparable with that found in other studies [22, 29, 30] , with RSV being the most frequently isolated agent. In the present study, the role of rhinoviruses may have been underestimated as a result of the relative insensitivity of the culture technique for the detection of these viruses. Application of the PCR in this field is also indicated, particularly in asthma, in which rhinoviruses are thought to be important triggers of exacerbations [31] . During the season studied, there was very low activity of parainfluenza virus. The herpes simplex and vari-.cella-zoster virus strains detected probably represent primary infections with these viruses, in view of the age of the patients.
An etiologic agent was detected twice as frequently, 40.8%, in lower compared with upper respiratory tract infections (common cold and laryngitis; 22.4%). M. pneumoniae was an important pathogen of lower respiratory tract infections: RSV, influenza virus, and M. pneumoniae were isolated in 8.9%, 5.3%, and 0.5% of upper respiratory tract infections, respectively, whereas in lower respiratory tract infections, these figures are 22.6%, 5.9%, and 5.9%, respectively. In bronchopneumonia and lobar pneumonia, RSV and M. pneumoniae were equally important, with 7 and 6 isolates respectively.
Overall, with the techniques applied, an etiologic agent was detected in 30.7% of specimens of acute respiratory tract infections in children. If, in addition, it is assumed that as a result of collection of some samples late in the evolution of disease, previous administration of antibiotics, and the sensitivity of the detection techniques used, the maximum detectability of an etiologic agent in acute respiratory tract infections is 85%-90%, this means that ,...., 50% of these infections in children remain etiologically undiagnosed. The importance of improved techniques for the detection of viruses such as rhinoviruses and the role of other agents such as Chlamydia pneumoniae, coronaviruses, and perhaps presently unknown microorganisms remain to be determined.
In conclusion, we recommend for detection of M. pneumoniae in the clinical diagnostic laboratory a PCR protocol involving freeze-boiling of the samples, amplification of the PI gene in the presence of a specific internal control, and detection of the amplicons by visual inspection of the gel. This procedure results in a sensitivity of 84.6% and a specificity of 92.3%. It should allow the rapid diagnosis of the great majority of infections by M pneumoniae that may be responsible for up to 12% of pediatric lower respiratory tract infections in children, particularly above the age of 2 years. Rapid etiologic diagnosis of these infections should allow initiation of proper antibiotic treatment, resulting in a reduced antibiotic pressure.
